|
Dec 8
|
Will Bristol Myers' (BMY) Efforts to Boost Portfolio be Enough?
|
|
Dec 7
|
12 Biggest Financial Scandals in US History
|
|
Dec 7
|
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
|
|
Dec 7
|
Bristol Myers Squibb Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Compared to Chemotherapy in Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer Meets Primary...
|
|
Dec 7
|
Bristol Myers Squibb Announces Additional $3 Billion Share Repurchase Authorization
|
|
Dec 6
|
Bristol Myers Squibb Announces Dividend Increase
|
|
Dec 6
|
Hedge Funds are Betting on These 14 Sliding Stocks
|
|
Dec 6
|
15 Best Safe Dividend Stocks For 2024
|
|
Dec 6
|
Bristol Myers' (BMY) Opdivo sBLA Gets FDA's Priority Review
|
|
Dec 5
|
3 Dirt Cheap Stocks That Could Skyrocket
|
|
Dec 5
|
12 Best Healthcare Dividend Stocks To Buy Now
|
|
Dec 5
|
Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet
|
|
Dec 5
|
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy for the First-Line Treatment of Adult Patients with Unresectable or Metastatic...
|
|
Dec 1
|
Bristol Myers Squibb CEO Chris Boerner Buys Up Stock
|
|
Dec 1
|
Insider Buying: CEO Christopher Boerner Acquires Shares of Bristol-Myers Squibb Co
|
|
Dec 1
|
The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
|
|
Dec 1
|
Bristol Myers Stock Is Slumping. One Director Bought Up Shares.
|
|
Nov 30
|
Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
|
|
Nov 30
|
Insiders At Bristol-Myers Squibb Sold US$23m In Stock, Alluding To Potential Weakness
|
|
Nov 30
|
13 Best Stocks Under $50 To Buy Now
|